IN VIVO TRACKING UNCOVERS AGE-DEPENDENT DIVERGENCE IN TUBULAR CELL CYCLE RESPONSE FOLLOWING KIDNEY INJURY

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
IN VIVO TRACKING UNCOVERS AGE-DEPENDENT DIVERGENCE IN TUBULAR CELL CYCLE RESPONSE FOLLOWING KIDNEY INJURY

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Keisuke
Morita
Keisuke Morita kemorita@kuhp.kyoto-u.ac.jp Kyoto University Graduate School of Medicine Nephrology Kyoto Japan *
Yohei Iwashige yiwashige@kuhp.kyoto-u.ac.jp Kyoto University Graduate School of Medicine Nephrology Kyoto Japan -
Ryo Yamada ryamada@kuhp.kyoto-u.ac.jp Kyoto University Graduate School of Medicine Nephrology Kyoto Japan -
Ryo Konishi rkonishi@kuhp.kyoto-u.ac.jp Kyoto University Graduate School of Medicine Nephrology Kyoto Japan -
Hiroyuki Ikeda hikeda11@kuhp.kyoto-u.ac.jp Kyoto University Graduate School of Medicine Nephrology Kyoto Japan -
Takuya Morinishi morinishit@kuhp.kyoto-u.ac.jp Kyoto University Graduate School of Medicine Nephrology Kyoto Japan -
Koji Muro muro_koji@kuhp.kyoto-u.ac.jp Kyoto University Graduate School of Medicine Nephrology Kyoto Japan -
Shigenori Yamamoto syamamot@kuhp.kyoto-u.ac.jp Kyoto University Graduate School of Medicine Nephrology Kyoto Japan -
Hideki Katagiri hideki.katagiri.e1@tohoku.ac.jp Tohoku University Graduate School of Medicine Diabetes, Metabolism and Endocrinology Sendai Japan -
Motoko Yanagita motoy@kuhp.kyoto-u.ac.jp Kyoto University Graduate School of Medicine Nephrology Kyoto Japan -
 
 
 
 
 

A substantial proportion of kidney proximal tubular cells (PTCs) initiate the cell cycle following kidney injury. Previous research has indicated that cell cycle progression during the acute phase may be associated with the severity of tissue damage in the later phase. However, conventional methods for evaluating cell cycle progression rely on “snapshot” images of fixed tissue samples, making it impossible to monitor cell cycle progression over time after kidney injury. Furthermore, the impact of aging on post-injury cell cycle entry remains unclear.

We utilized proximal tubule-specific hKi67p-Gaussia luciferase (Gluc) transgenic mice (Nature Communications, 2023), wherein Gluc is transcribed under the human Ki67 promoter, and serum Gluc activities serves as an indicator of PTCs-specific Mki67 transcription through its secretion into the circulation. Unilateral ischemia-reperfusion injury (IRI) was induced in young (8 weeks old) and aged (12 months old) transgenic male mice, followed by multiple blood collections for luminescence assays up to post-IRI day 14. We analyzed the association between the serum Gluc activities and kidney fibrosis in the chronic phase.

First, we conducted quantitative PCR 2 days post injury, which showed serum Gluc activity was positively correlated with Mki67, confirming Gluc activity works as an indicator of PTC proliferation in these transgenic mice. In a 30-minute ischemia model using young mice, Gluc activity increased during the acute phase, peaking on day 2 and returning to baseline by day 5. In contrast, in the 45-minute ischemia model, Gluc peak activity was significantly higher and occurred later compared to the 30-minute model. Furthermore, recovery of serum Gluc activity to baseline levels was delayed until day 14. In both 30-minute and 45-minute ischemia models using young mice, Gluc peak activities were positively correlated with kidney fibrosis in the chronic phase. 

In aged mice, Gluc activity peaked on day 3 in the 30-minute ischemia model and recovered to near baseline levels by day 14. When compared to the same model in young mice, Gluc peak activities showed no significant difference between the two groups, whereas kidney fibrosis was markedly more severe in the aged mice. 

In a milder injury model, 23-minute IRI, in aged mice, Gluc peak activities was observed earlier on day 2, compared to a 30-minute model. Conversely, the extent of fibrosis on day 14 showed no significant difference between 23-minute and 30-minute ischemia groups. Additionally, unlike in young mice, Gluc peak activities in aged mice did not correlate with kidney fibrosis in the chronic phase.

Using this novel in vivo tracking method, we, for the first time, enabled the ex vivo diagnosis of PTC proliferation during kidney injury. Furthermore, we found that in young mice, PTC proliferation during the acute phase correlated with kidney fibrosis in the chronic phase. In contrast, in aged mice, the degree of acute-phase PTC proliferation did not significantly differ from that in young mice, whereas the association with chronic-phase fibrosis was lost. This technique is an extremely useful tool for clarifying the relationship between PTC proliferation and the progression of kidney disease, which had previously been inferred from snapshot observations.

This work was first presented at ASN Kidney Week 2025, and re-submission is permitted by ASN.  

Kewords